摘要
观察81例原发性高脂血症患者用不同剂量血脂康的治疗效果,随机分为2组,A组(39例)服血脂康2粒/次,早晚各1次(1.2g/d),B组(42例)服血脂康3粒/d,每晚1次(0.9g/d),疗程均为8周。结果显示服血脂康后两组各血脂水平与治疗前比较,TC、TG、LDLC、(TC-HDLC)/HDLC均明显下降(P<0.01~<0.001),HDLC明显上升(P<0.01);不同剂量血脂康降TC、TG、LDLC、(TC-HDLC)/HDLC,升HDLC的幅度无明显差异(P均>0.05)。提示每晚服3粒血脂康可获得较好的降脂疗效。
The study was conducted on 81 patients with primary hyperlipidemia.They were randomly divided to receive 4 capsules daily (1.2 g/d)(n=39) or 3 capsules daily (0.9 g/d)(n=42)for 8 weeks.At the end of the study the serum TC,TG,LDL C and (TC-HDL C)/HDL C were all decreased in both groups in comparison with baseline values and the serum HDL C was all increased in both groups and no significant difference were observed.Therefore,the effective dose of Xuezhikang capsule should be 3 capsule daily.
出处
《中国新药杂志》
CAS
CSCD
1997年第6期430-433,共4页
Chinese Journal of New Drugs